Gonçalo Manuel Rodrigues, João Albuquerque e Castro, Frederico Bastos Gonçalves, Anita Quintas, Rodolfo Abreu, Rita Ferreira, Nelson Camacho, Hugo Valentim, Ana Garcia, Maria Emília Ferreira, Luís Mota Capitão
{"title":"Correção endovascular de aneurismas da aorta abdominal em doentes com anatomia desfavorável: resultados institucionais a curto e médio prazo","authors":"Gonçalo Manuel Rodrigues, João Albuquerque e Castro, Frederico Bastos Gonçalves, Anita Quintas, Rodolfo Abreu, Rita Ferreira, Nelson Camacho, Hugo Valentim, Ana Garcia, Maria Emília Ferreira, Luís Mota Capitão","doi":"10.1016/j.ancv.2015.07.003","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><p>The goal of this study is to determine the influence of abdominal aortic aneurysm (AAA) anatomy in endovascular aneurysm repair (EVAR) short and mid‐term outcomes.</p></div><div><h3>Methods</h3><p>A total of 112 patients underwent programed aorto‐biiliac EVAR at a single center between January 2011 and December 2013. Pre and postoperative imaging follow‐up were retrospectively reviewed and anatomical measures were calculated on Osirix<em>®</em> with center lumen line. Only patients with a postoperative imaging follow‐up of more than 12 months were included, resulting in the exclusion of thirty three (29%) cases. Patients were divided into 2 groups: the “<em>EVAR suitable anatomy</em>” group (f‐IFU) and the “<em>EVAR challenging anatomy</em>” group (df‐IFU).</p></div><div><h3>Results</h3><p>A total of 35.5% (n<!--> <!-->=<!--> <!-->28) patients were in the df‐IFU group. These patients had larger AAA diameter (64.4<!--> <!-->±<!--> <!-->10.1<!--> <!-->mm <em>vs</em> 60.6<!--> <!-->±<!--> <!-->10.8<!--> <!-->mm) and shorter proximal neck (19.8<!--> <!-->±<!--> <!-->11.8<!--> <!-->mm <em>vs</em> 30.4<!--> <!-->±<!--> <!-->14.4<!--> <!-->mm) (p<!--> <!--><<!--> <!-->0.05).</p><p>The device preferentially used was <em>Endurant</em>® (54,5%). The df‐IFU group was more likely to be treated with suprarenal fixation devices (85.7% df‐IFU <em>vs</em> 69% f‐IFU, p<!--> <!-->=<!--> <!-->.048).</p><p>Mean follow‐up was 21,9<!--> <!-->±<!--> <!-->9,8 months (12‐46).</p><p>Perioperative mortality (0% df‐IFU <em>vs</em> 2% f‐IFU) and all‐cause mortality rates (12% df‐IFU <em>vs</em> 11,9% f‐IFU) were similar between the two groups (p<!--> <!-->><!--> <!-->0.05). There was no significant difference in <em>endoleak</em> rate (short‐term 25% df‐IFU <em>vs</em> 22% f‐IFU; mid‐term 12% df‐IFU <em>vs</em> 23.8% f‐IFU) and in re‐intervention rates (short‐term 7.2% df‐IFU <em>vs</em> 8% f‐IFU; mid‐term 4% df‐IFU <em>vs</em> 4.8% f‐IFU)(p<!--> <!-->><!--> <!-->0.05).</p></div><div><h3>Conclusion</h3><p>Endovascular treatment of AAA patients with challenging anatomy for EVAR provided acceptable short and mid‐term results that are comparable to those in patients with suitable anatomy. Long‐term follow‐up is unreliable necessary to confirm these results.</p></div>","PeriodicalId":30341,"journal":{"name":"Angiologia e Cirurgia Vascular","volume":"11 3","pages":"Pages 158-165"},"PeriodicalIF":0.0000,"publicationDate":"2015-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.ancv.2015.07.003","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Angiologia e Cirurgia Vascular","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1646706X15000762","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Background
The goal of this study is to determine the influence of abdominal aortic aneurysm (AAA) anatomy in endovascular aneurysm repair (EVAR) short and mid‐term outcomes.
Methods
A total of 112 patients underwent programed aorto‐biiliac EVAR at a single center between January 2011 and December 2013. Pre and postoperative imaging follow‐up were retrospectively reviewed and anatomical measures were calculated on Osirix® with center lumen line. Only patients with a postoperative imaging follow‐up of more than 12 months were included, resulting in the exclusion of thirty three (29%) cases. Patients were divided into 2 groups: the “EVAR suitable anatomy” group (f‐IFU) and the “EVAR challenging anatomy” group (df‐IFU).
Results
A total of 35.5% (n = 28) patients were in the df‐IFU group. These patients had larger AAA diameter (64.4 ± 10.1 mm vs 60.6 ± 10.8 mm) and shorter proximal neck (19.8 ± 11.8 mm vs 30.4 ± 14.4 mm) (p < 0.05).
The device preferentially used was Endurant® (54,5%). The df‐IFU group was more likely to be treated with suprarenal fixation devices (85.7% df‐IFU vs 69% f‐IFU, p = .048).
Mean follow‐up was 21,9 ± 9,8 months (12‐46).
Perioperative mortality (0% df‐IFU vs 2% f‐IFU) and all‐cause mortality rates (12% df‐IFU vs 11,9% f‐IFU) were similar between the two groups (p > 0.05). There was no significant difference in endoleak rate (short‐term 25% df‐IFU vs 22% f‐IFU; mid‐term 12% df‐IFU vs 23.8% f‐IFU) and in re‐intervention rates (short‐term 7.2% df‐IFU vs 8% f‐IFU; mid‐term 4% df‐IFU vs 4.8% f‐IFU)(p > 0.05).
Conclusion
Endovascular treatment of AAA patients with challenging anatomy for EVAR provided acceptable short and mid‐term results that are comparable to those in patients with suitable anatomy. Long‐term follow‐up is unreliable necessary to confirm these results.
本研究的目的是确定腹主动脉瘤(AAA)解剖对血管内动脉瘤修复(EVAR)短期和中期结果的影响。方法2011年1月至2013年12月,112例患者在同一中心接受程序化主动脉-胆道EVAR。回顾性回顾了术前和术后影像学随访,并计算了Osirix®中心管腔线的解剖测量。仅纳入术后影像学随访超过12个月的患者,排除了33例(29%)病例。患者分为2组:“EVAR适宜解剖”组(f‐IFU)和“EVAR挑战解剖”组(df‐IFU)。结果df - IFU组共有35.5% (n = 28)患者。这些患者的AAA直径较大(64.4±10.1 mm vs 60.6±10.8 mm),颈近端较短(19.8±11.8 mm vs 30.4±14.4 mm) (p <0.05)。优先使用的设备是Endurant®(54.5%)。df - IFU组更有可能使用肾上固定装置(85.7% df - IFU vs 69% f - IFU, p = 0.048)。平均随访时间为21,9±9,8个月(12 - 46)。两组围手术期死亡率(0% df - IFU vs 2% f - IFU)和全因死亡率(12% df - IFU vs 11.9% f - IFU)相似(p >0.05)。内漏率无显著差异(短期25% df - IFU vs 22% f - IFU;中期12% df - IFU vs 23.8% f - IFU)和再干预率(短期7.2% df - IFU vs 8% f - IFU;中期4% df - IFU vs 4.8% f - IFU)(p >0.05)。结论:与具有合适解剖结构的AAA级EVAR患者相比,血管内治疗具有可接受的短期和中期结果。要证实这些结果,长期随访是不可靠的。